Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells.
第一作者:
Jordi M,Serra
第一单位:
Department of Hematology, Institut Universitari d'Investigacions en Ciències de la Salut, University Hospital Son Dureta, c/Andrea Dòria 55, E-07014 Palma de Mallorca, Spain. jmserra@hsd.es
作者:
医学主题词
抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);细胞分化(Cell Differentiation);细胞系, 肿瘤(Cell Line, Tumor);DNA结合蛋白质类(DNA-Binding Proteins);脱氧胞苷(Deoxycytidine);减量调节(Down-Regulation);酶激活(Enzyme Activation);细胞外信号调节MAP激酶类(Extracellular Signal-Regulated MAP Kinases);人类(Humans);肺肿瘤(Lung Neoplasms);甲氨蝶呤(Methotrexate);转录因子(Transcription Factors)
DOI
10.1124/mol.107.043372
PMID
18353995
发布时间
2025-02-13
- 浏览16
Molecular pharmacology
1679-87页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



